Megadose bromazepam and zolpidem dependence: Two case reports of treatment with flumazenil and valproate

Substance Abuse

Volumn 33, Issue 2, 2012, Pages 195-198

  Quaglio, Gianluca ^a   Faccini, Marco ^a   Vigneau, Caroline Victorri ^b   Casari, Rebecca ^a   Mathewson, Sophie ^a   Licata, Manuela ^c   Lugoboni, Fabio ^a  

^a Azienda Ospedaliera Universitaria   (Italy)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; BROMAZEPAM; FLUMAZENIL; PYRIDINE DERIVATIVE; VALPROIC ACID; ZOLPIDEM;

ADDICTION; ADULT; CASE REPORT; FEMALE; HUMAN; LETTER;

ADULT; ANTICONVULSANTS; BROMAZEPAM; FEMALE; FLUMAZENIL; GABA MODULATORS; GABA-A RECEPTOR AGONISTS; HUMANS; PYRIDINES; SUBSTANCE-RELATED DISORDERS; VALPROIC ACID;

EID: 84859728168     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2011.638735     Document Type: Letter

References (12)

1. Gerra G, Zaimovic A, Giusti F, Moi G, Brewer C. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study. Addict Biol. 2002;7:385-395.
2. Quaglio GL, Lugoboni F, Fornasiero A, Lechi A, Gerra G, Mezzelani P. Dependence on zolpidem: two case reports of detoxification with flumazenil infusion. Int Clin Psychopharmacol. 2005;20:285-287.
3. Lugoboni F, Faccini M, Quaglio GL, Albiero A, Pajusco B. Intravenous flumazenil infusion to treat benzodiazepine dependence should be performed in the inpatient clinical setting for high risk of seizure. J Psychopharmacol. 2011;25:848-849.
4. Zullino DF, Khazaal Y, Ḧattenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today. 2004;40:603-619.
5. Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol. 2007;64:198-209.
6. Greenblatt DJ, Harmatz JS, von Moltke LL, et al. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. J Pharmacol Exp Ther. 2000;293:435-443.
7. Prabhat K, Murthy C, Murthy P. Mega dose lorazepam dependence. Addiction. 2003;98:1635-1636.
8. Mowla A, Firoozabadi A, Haghighi AB, Sahraian A. Megadose clonazepam dependance. J Clin Psychopharmacol. 2007;27:542-543.
9. Vorma H, Naukkarinen H, Sarna S, Kuoppasalmi K. Treatment of out-patients with complicated benzodiazepine dependence: comparison of two approaches. Addiction. 2002;97:851-859.
10. Hood S, O'Neil G, Hulse G. The role of flumazenil in the treatment of benzodiazepine dependence: physiological and psychological profiles. J Psychopharmacol. 2009;23:401-409.
11. Michaud K, Romain N, Giroud C, Brandt C, Mangin P. Hypothermia and undressing associated with non-fatal bromazepam intoxication. Forensic Sci. Int. 2001;124:112-114.
12. Huang MC, Lin HY, Chen CH. Dependence on zolpidem. Psychiatry Clin Neurosci 2007;61:207-208.